Alina Markova

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Alina Markova

Apr 14, 2024, 07:51 | Insight

New Paper Alert! Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach

Defining Dermatologic Immune-Related Adverse Events: A Consensus-Driven Approach Published in Journal for ImmunoTherapy of Cancer,…

Dec 21, 2023, 10:30 | Blog

MSKCC experts presented research related to managing and reducing treatment-related toxicities at the ASH - Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center shared on LinkedIn: ''Memorial Sloan Kettering Cancer Center (MSK) experts,…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023